Rapa Therapeutics LLC

Quick facts

Phase 2 pipeline

• Chemotherapy Prior to RAPA-201 Therapy
• RAPA-201 Autologous T cells
• RAPA-201 Rapamycin Resistant T Cells
• RAPA-501 Autologous T stem cells

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Rapa Therapeutics LLC portfolio CI brief
• Rapa Therapeutics LLC pipeline updates RSS